Lifeward Ltd. Regains Compliance with Nasdaq Minimum Bid Price Requirement
Lifeward Ltd. (NASDAQ: LFWD), formerly known as ReWalk Robotics Ltd. and Argo Medical Technologies Ltd., announced a significant development that could impact shareholders and the company’s share price. On March 10, 2026, the company received a written notice from the Nasdaq Listing Qualifications Hearings Department confirming that Lifeward Ltd. has regained compliance with the Nasdaq Capital Market’s Minimum Bid Price Requirement (Listing Rule 5550(a)(2)).
Key Points of the Report
- Compliance Regained: Lifeward Ltd. has maintained a minimum closing bid price of at least \$1.00 per share for the last 10 consecutive business days, from February 24, 2026, through March 9, 2026.
- Nasdaq Confirmation: Based on this performance, Nasdaq staff has determined that the company is now in full compliance with its listing rule regarding minimum bid price, and the matter is officially closed.
- Shareholder Implications: Failure to comply with the minimum bid price requirement can result in delisting from Nasdaq, which typically has severe negative consequences for liquidity, investor confidence, and share price. Regaining compliance averts this risk and is a positive signal for the company’s stability and ongoing access to capital markets.
- Corporate Identity: The company has undergone several name changes, previously operating as ReWalk Robotics Ltd. and Argo Medical Technologies Ltd. Its ordinary shares (par value NIS 0.25) continue to trade under the symbol LFWD on the Nasdaq Capital Market.
- Corporate Structure and Contact: Lifeward Ltd. is incorporated in jurisdiction code “L3” (likely Israel), with business operations at 200 Donald Lynch Blvd., Marlborough, MA 01752. The company’s EIN is listed as 00-0000000, and its Chief Financial Officer is Almog Adar.
- Emerging Growth Company Status: The company is not classified as an emerging growth company under current SEC rules, which may have implications for disclosure requirements and regulatory obligations.
What Shareholders Need to Know
- This announcement removes the immediate threat of Nasdaq delisting due to share price non-compliance, which could have caused significant downward pressure on the stock and limited access to institutional investors.
- Regaining compliance may restore investor confidence and enhance the company’s reputation in the capital markets, possibly driving increased trading volumes and share price stability.
- No new securities offerings, tender offers, or proxy solicitations are simultaneously being announced in this filing.
- Shareholders should be aware that continued compliance is necessary to maintain the listing; any future dips below the \$1.00 bid price could trigger renewed scrutiny from Nasdaq.
Potential Price Sensitivity
The confirmation of regained compliance with Nasdaq’s Minimum Bid Price Requirement is a material development. It eliminates the risk of near-term delisting, which can be highly price-sensitive for listed companies, especially those with a history of share price volatility. Investors should view this as a positive resolution to a potentially adverse situation.
Additional Company Information
- Trading Symbol: LFWD
- Security Title: Ordinary Shares, par value NIS 0.25
- Exchange: Nasdaq Capital Market
- Commission File Number: 001-36612
- Contact: +508.251.1154 (main), 4.959.0123 (local)
- Chief Financial Officer: Almog Adar
Disclaimer: This article is a summary of an official SEC filing and is intended for information purposes only. It does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult a financial advisor regarding Lifeward Ltd. or any other investment.
View Lifeward Ltd. Historical chart here
